Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $318.64M.
ENTERPRISE VALUE (EV)
$318.64M
Fennec Pharmaceuticals Inc.
Market Cap
$355.36M
Enterprise Value (EV)
$318.64M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Fennec Pharmaceuticals Inc. (FENC) | $355.36M | $318.64M |
| Embecta Corp. (EMBC)vs › | $351.97M | $1.64B |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $351.32M | $373.55M |
| Opus Genetics, Inc. (IRD)vs › | $348.84M | $294.96M |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $341.25M | $49.65M |
| Canopy Growth Corporation (CGC)vs › | $370.48M | $328.74M |
| ClearPoint Neuro, Inc. (CLPT)vs › | $333.18M | $367.77M |
| Agenus Inc. (AGEN)vs › | $333.14M | $355.11M |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $376.63M | $377.82M |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $379.73M | $211.18M |
Market Cap
$355.36M
Total Debt
$0.00
Cash
$36.72M
Enterprise Value
$318.64M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
